pre-miRNA Information | |
---|---|
pre-miRNA | hsa-mir-4534 |
Genomic Coordinates | chr22: 37988794 - 37988853 |
Description | Homo sapiens miR-4534 stem-loop |
Comment | None |
RNA Secondary Structure |
Mature miRNA Information | |||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mature miRNA | hsa-miR-4534 | ||||||||||||
Sequence | 36| GGAUGGAGGAGGGGUCU |52 | ||||||||||||
Evidence | Experimental | ||||||||||||
Experiments | Illumina | ||||||||||||
SNPs in miRNA |
|
||||||||||||
Putative Targets |
miRNA Expression profile | |
---|---|
Human miRNA Tissue Atlas | |
Circulating MicroRNA Expression Profiling |
Gene Information | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene Symbol | RRM2 | ||||||||||||||||||||
Synonyms | R2, RR2, RR2M | ||||||||||||||||||||
Description | ribonucleotide reductase regulatory subunit M2 | ||||||||||||||||||||
Transcript | NM_001034 | ||||||||||||||||||||
Other Transcripts | NM_001165931 | ||||||||||||||||||||
Expression | |||||||||||||||||||||
Putative miRNA Targets on RRM2 | |||||||||||||||||||||
3'UTR of RRM2 (miRNA target sites are highlighted) |
>RRM2|NM_001034|3'UTR 1 ATGAACTGAAGATGTGCCCTTACTTGGCTGATTTTTTTTTTCCATCTCATAAGAAAAATCAGCTGAAGTGTTACCAACTA 81 GCCACACCATGAATTGTCCGTAATGTTCATTAACAGCATCTTTAAAACTGTGTAGCTACCTCACAACCAGTCCTGTCTGT 161 TTATAGTGCTGGTAGTATCACCTTTTGCCAGAAGGCCTGGCTGGCTGTGACTTACCATAGCAGTGACAATGGCAGTCTTG 241 GCTTTAAAGTGAGGGGTGACCCTTTAGTGAGCTTAGCACAGCGGGATTAAACAGTCCTTTAACCAGCACAGCCAGTTAAA 321 AGATGCAGCCTCACTGCTTCAACGCAGATTTTAATGTTTACTTAAATATAAACCTGGCACTTTACAAACAAATAAACATT 401 GTTTGTACTCACAAGGCGATAATAGCTTGATTTATTTGGTTTCTACACCAAATACATTCTCCTGACCACTAATGGGAGCC 481 AATTCACAATTCACTAAGTGACTAAAGTAAGTTAAACTTGTGTAGACTAAGCATGTAATTTTTAAGTTTTATTTTAATGA 561 ATTAAAATATTTGTTAACCAACTTTAAAGTCAGTCCTGTGTATACCTAGATATTAGTCAGTTGGTGCCAGATAGAAGACA 641 GGTTGTGTTTTTATCCTGTGGCTTGTGTAGTGTCCTGGGATTCTCTGCCCCCTCTGAGTAGAGTGTTGTGGGATAAAGGA 721 ATCTCTCAGGGCAAGGAGCTTCTTAAGTTAAATCACTAGAAATTTAGGGGTGATCTGGGCCTTCATATGTGTGAGAAGCC 801 GTTTCATTTTATTTCTCACTGTATTTTCCTCAACGTCTGGTTGATGAGAAAAAATTCTTGAAGAGTTTTCATATGTGGGA 881 GCTAAGGTAGTATTGTAAAATTTCAAGTCATCCTTAAACAAAATGATCCACCTAAGATCTTGCCCCTGTTAAGTGGTGAA 961 ATCAACTAGAGGTGGTTCCTACAAGTTGTTCATTCTAGTTTTGTTTGGTGTAAGTAGGTTGTGTGAGTTAATTCATTTAT 1041 ATTTACTATGTCTGTTAAATCAGAAATTTTTTATTATCTATGTTCTTCTAGATTTTACCTGTAGTTCATACTTCAGTCAC 1121 CCAGTGTCTTATTCTGGCATTGTCTAAATCTGAGCATTGTCTAGGGGGATCTTAAACTTTAGTAGGAAACCATGAGCTGT 1201 TAATACAGTTTCCATTCAAATATTAATTTCAGAATGAAACATAATTTTTTTTTTTTTTTTTGAGATGGAGTCTCGCTCTG 1281 TTGCCCAGGCTGGAGTGCAGTGGCGCGATTTTGGCTCACTGTAACCTCCATCTCCTGGGTTCAAGCAATTCTCCTGTCTC 1361 AGCCTCCCTAGTAGCTGGGACTGCAGGTATGTGCTACCACACCTGGCTAATTTTTGTATTTTTAGTAGAGATGGAGTTTC 1441 ACCATATTGGTCAGGCTGGTCTTGAACTCCTGACCTCAGGTGATCCACCCACCTCGGCCTCCCAAAGTGCTGGGATTGCA 1521 GGCGTGATAAACAAATATTCTTAATAGGGCTACTTTGAATTAATCTGCCTTTATGTTTGGGAGAAGAAAGCTGAGACATT 1601 GCATGAAAGATGATGAGAGATAAATGTTGATCTTTTGGCCCCATTTGTTAATTGTATTCAGTATTTGAACGTCGTCCTGT 1681 TTATTGTTAGTTTTCTTCATCATTTATTGTATAGACAATTTTTAAATCTCTGTAATATGATACATTTTCCTATCTTTTAA 1761 GTTATTGTTACCTAAAGTTAATCCAGATTATATGGTCCTTATATGTGTACAACATTAAAATGAAAGGCTTTGTCTTGCAT 1841 TGTGAGGTACAGGCGGAAGTTGGAATCAGGTTTTAGGATTCTGTCTCTCATTAGCTGAATAATGTGAGGATTAACTTCTG 1921 CCAGCTCAGACCATTTCCTAATCAGTTGAAAGGGAAACAAGTATTTCAGTCTCAAAATTGAATAATGCACAAGTCTTAAG 2001 TGATTAAAATAAAACTGTTCTTATGTCAGTTTCAAAAAAAAAAAAAAAAAA Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
||||||||||||||||||||
miRNA-target interactions (Predicted by miRanda) |
|
||||||||||||||||||||
DRVs in gene 3'UTRs | |||||||||||||||||||||
SNPs in gene 3'UTRs |
Experimental Support 1 for Functional miRNA-Target Interaction | |||||||
---|---|---|---|---|---|---|---|
miRNA:Target | ---- | ||||||
Validation Method |
|
||||||
Conditions | HEK293 | ||||||
Disease | 6241.0 | ||||||
Location of target site | 3'UTR | ||||||
Tools used in this research | TargetScan , miRTarCLIP , Piranha | ||||||
Original Description (Extracted from the article) |
...
"PAR-CLIP data was present in GSM714644. RNA binding protein: AGO2. Condition:completeT1
... - Kishore S; Jaskiewicz L; Burger L; Hausser et al., 2011, Nature methods. |
||||||
miRNA-target interactions (Provided by authors) |
|
||||||
Article |
- Kishore S; Jaskiewicz L; Burger L; Hausser et al. - Nature methods, 2011
Cross-linking and immunoprecipitation (CLIP) is increasingly used to map transcriptome-wide binding sites of RNA-binding proteins. We developed a method for CLIP data analysis, and applied it to compare CLIP with photoactivatable ribonucleoside-enhanced CLIP (PAR-CLIP) and to uncover how differences in cross-linking and ribonuclease digestion affect the identified sites. We found only small differences in accuracies of these methods in identifying binding sites of HuR, which binds low-complexity sequences, and Argonaute 2, which has a complex binding specificity. We found that cross-link-induced mutations led to single-nucleotide resolution for both PAR-CLIP and CLIP. Our results confirm the expectation from original CLIP publications that RNA-binding proteins do not protect their binding sites sufficiently under the denaturing conditions used during the CLIP procedure, and we show that extensive digestion with sequence-specific RNases strongly biases the recovered binding sites. This bias can be substantially reduced by milder nuclease digestion conditions.
LinkOut: [PMID: 21572407]
|
Experimental Support 2 for Functional miRNA-Target Interaction | |||||||
---|---|---|---|---|---|---|---|
miRNA:Target | ---- | ||||||
Validation Method |
|
||||||
Conditions | TZM-bl | ||||||
Location of target site | 3'UTR | ||||||
Tools used in this research | TargetScan , miRTarCLIP , Piranha | ||||||
Original Description (Extracted from the article) |
...
PAR-CLIP data was present in GSM1462574. RNA binding protein: AGO2. Condition:TZM-bl ami BaL
... - Whisnant AW; Bogerd HP; Flores O; Ho P; et al., 2013, mBio. |
||||||
miRNA-target interactions (Provided by authors) |
|
||||||
Article |
- Whisnant AW; Bogerd HP; Flores O; Ho P; et al. - mBio, 2013
UNLABELLED: The question of how HIV-1 interfaces with cellular microRNA (miRNA) biogenesis and effector mechanisms has been highly controversial. Here, we first used deep sequencing of small RNAs present in two different infected cell lines (TZM-bl and C8166) and two types of primary human cells (CD4(+) peripheral blood mononuclear cells [PBMCs] and macrophages) to unequivocally demonstrate that HIV-1 does not encode any viral miRNAs. Perhaps surprisingly, we also observed that infection of T cells by HIV-1 has only a modest effect on the expression of cellular miRNAs at early times after infection. Comprehensive analysis of miRNA binding to the HIV-1 genome using the photoactivatable ribonucleoside-induced cross-linking and immunoprecipitation (PAR-CLIP) technique revealed several binding sites for cellular miRNAs, a subset of which were shown to be capable of mediating miRNA-mediated repression of gene expression. However, the main finding from this analysis is that HIV-1 transcripts are largely refractory to miRNA binding, most probably due to extensive viral RNA secondary structure. Together, these data demonstrate that HIV-1 neither encodes viral miRNAs nor strongly influences cellular miRNA expression, at least early after infection, and imply that HIV-1 transcripts have evolved to avoid inhibition by preexisting cellular miRNAs by adopting extensive RNA secondary structures that occlude most potential miRNA binding sites. IMPORTANCE: MicroRNAs (miRNAs) are a ubiquitous class of small regulatory RNAs that serve as posttranscriptional regulators of gene expression. Previous work has suggested that HIV-1 might subvert the function of the cellular miRNA machinery by expressing viral miRNAs or by dramatically altering the level of cellular miRNA expression. Using very sensitive approaches, we now demonstrate that neither of these ideas is in fact correct. Moreover, HIV-1 transcripts appear to largely avoid regulation by cellular miRNAs by adopting an extensive RNA secondary structure that occludes the ability of cellular miRNAs to interact with viral mRNAs. Together, these data suggest that HIV-1, rather than seeking to control miRNA function in infected cells, has instead evolved a mechanism to become largely invisible to cellular miRNA effector mechanisms.
LinkOut: [PMID: 23592263]
|
CLIP-seq Support 1 for dataset GSM4903833 | |
---|---|
Method / RBP | HITS-CLIP / AGO |
Cell line / Condition | Dermal fibroblasts / CTL_TD_21_a |
Location of target site | NM_001165931 | 3UTR | AUCUCCUGGGUUCAAGCAAUUCUCCU |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Accession Series | GSE161239 |
CLIP-seq Viewer | Link |
CLIP-seq Support 2 for dataset GSM714644 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | HEK293 / completeT1, repA |
Location of target site | ENST00000360566.2 | 3UTR | UCUCCUGGGUUCAAGCAAU |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 21572407 / GSE28865 |
CLIP-seq Viewer | Link |
CLIP-seq Support 3 for dataset GSM1462574 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | TZM-bl / TZM-bl ami BaL |
Location of target site | ENST00000360566.2 | 3UTR | CUCACUGUAACCUCCAUCUCCUGGGUUCAAG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 23592263 / GSE59944 |
CLIP-seq Viewer | Link |
MiRNA-Target Expression Profile | |||||||
---|---|---|---|---|---|---|---|
|
MiRNA-Target Expression Profile (TCGA) | |||||||
---|---|---|---|---|---|---|---|
|
141 hsa-miR-4534 Target Genes:
Functional analysis:
ID | Target | Description | Validation methods | |||||||||
Strong evidence | Less strong evidence | |||||||||||
MIRT087131 | CRKL | CRK like proto-oncogene, adaptor protein | 2 | 2 | ||||||||
MIRT179641 | CAPZA1 | capping actin protein of muscle Z-line alpha subunit 1 | 2 | 2 | ||||||||
MIRT243304 | SLC25A36 | solute carrier family 25 member 36 | 2 | 2 | ||||||||
MIRT325574 | HIATL1 | major facilitator superfamily domain containing 14B | 2 | 4 | ||||||||
MIRT448776 | GNA13 | G protein subunit alpha 13 | 2 | 2 | ||||||||
MIRT451456 | HSD11B1L | hydroxysteroid 11-beta dehydrogenase 1 like | 2 | 2 | ||||||||
MIRT452150 | PPP2R1B | protein phosphatase 2 scaffold subunit Abeta | 2 | 2 | ||||||||
MIRT454199 | HLA-A | major histocompatibility complex, class I, A | 2 | 2 | ||||||||
MIRT455984 | ENPP5 | ectonucleotide pyrophosphatase/phosphodiesterase 5 (putative) | 2 | 2 | ||||||||
MIRT456058 | SLC25A28 | solute carrier family 25 member 28 | 2 | 2 | ||||||||
MIRT457082 | XPNPEP3 | X-prolyl aminopeptidase 3 | 2 | 2 | ||||||||
MIRT457278 | ALDH9A1 | aldehyde dehydrogenase 9 family member A1 | 2 | 2 | ||||||||
MIRT457361 | POFUT2 | protein O-fucosyltransferase 2 | 2 | 2 | ||||||||
MIRT457396 | CAMK2A | calcium/calmodulin dependent protein kinase II alpha | 2 | 2 | ||||||||
MIRT458817 | ZNF843 | zinc finger protein 843 | 2 | 2 | ||||||||
MIRT459697 | VPS37C | VPS37C, ESCRT-I subunit | 2 | 2 | ||||||||
MIRT460346 | ARL14EP | ADP ribosylation factor like GTPase 14 effector protein | 2 | 2 | ||||||||
MIRT462713 | MAPK13 | mitogen-activated protein kinase 13 | 2 | 2 | ||||||||
MIRT464278 | VASH1 | vasohibin 1 | 2 | 2 | ||||||||
MIRT465634 | TNRC18P2 | trinucleotide repeat containing 18 pseudogene 2 | 2 | 10 | ||||||||
MIRT465772 | TMOD3 | tropomodulin 3 | 2 | 2 | ||||||||
MIRT466414 | TFDP1 | transcription factor Dp-1 | 2 | 2 | ||||||||
MIRT467122 | SRGAP1 | SLIT-ROBO Rho GTPase activating protein 1 | 2 | 8 | ||||||||
MIRT467475 | SMYD1 | SET and MYND domain containing 1 | 2 | 4 | ||||||||
MIRT468462 | SET | SET nuclear proto-oncogene | 2 | 2 | ||||||||
MIRT468618 | SUMO1 | small ubiquitin-like modifier 1 | 2 | 2 | ||||||||
MIRT468835 | RRM2 | ribonucleotide reductase regulatory subunit M2 | 2 | 4 | ||||||||
MIRT470890 | PLXND1 | plexin D1 | 2 | 2 | ||||||||
MIRT473226 | SMCR7L | mitochondrial elongation factor 1 | 2 | 4 | ||||||||
MIRT473858 | MAP2K4 | mitogen-activated protein kinase kinase 4 | 2 | 2 | ||||||||
MIRT474975 | KCND3 | potassium voltage-gated channel subfamily D member 3 | 2 | 2 | ||||||||
MIRT475858 | H6PD | hexose-6-phosphate dehydrogenase/glucose 1-dehydrogenase | 2 | 2 | ||||||||
MIRT478569 | CTNND1 | catenin delta 1 | 2 | 2 | ||||||||
MIRT479347 | CEP97 | centrosomal protein 97 | 2 | 2 | ||||||||
MIRT479910 | CCDC117 | coiled-coil domain containing 117 | 2 | 4 | ||||||||
MIRT480122 | CALR | calreticulin | 2 | 2 | ||||||||
MIRT480892 | BCL9L | B-cell CLL/lymphoma 9 like | 2 | 2 | ||||||||
MIRT481149 | AVL9 | AVL9 cell migration associated | 2 | 6 | ||||||||
MIRT481527 | ARL5B | ADP ribosylation factor like GTPase 5B | 2 | 10 | ||||||||
MIRT481896 | ANKRD40 | ankyrin repeat domain 40 | 2 | 2 | ||||||||
MIRT490138 | FN3K | fructosamine 3 kinase | 2 | 4 | ||||||||
MIRT490329 | ANK1 | ankyrin 1 | 2 | 4 | ||||||||
MIRT491472 | TMEM214 | transmembrane protein 214 | 2 | 2 | ||||||||
MIRT503552 | TIGIT | T-cell immunoreceptor with Ig and ITIM domains | 2 | 4 | ||||||||
MIRT504413 | TUBA1B | tubulin alpha 1b | 2 | 4 | ||||||||
MIRT508207 | SLC35E1 | solute carrier family 35 member E1 | 2 | 2 | ||||||||
MIRT508333 | SLC37A4 | solute carrier family 37 member 4 | 2 | 6 | ||||||||
MIRT516381 | TRAF3IP2 | TRAF3 interacting protein 2 | 2 | 4 | ||||||||
MIRT518549 | ABCA6 | ATP binding cassette subfamily A member 6 | 2 | 2 | ||||||||
MIRT522545 | MED28 | mediator complex subunit 28 | 2 | 6 | ||||||||
MIRT522592 | MAPK1IP1L | mitogen-activated protein kinase 1 interacting protein 1 like | 2 | 2 | ||||||||
MIRT522923 | KAT6A | lysine acetyltransferase 6A | 2 | 4 | ||||||||
MIRT525937 | C11orf74 | chromosome 11 open reading frame 74 | 2 | 2 | ||||||||
MIRT527021 | PABPN1L | poly(A) binding protein nuclear 1 like, cytoplasmic | 2 | 2 | ||||||||
MIRT530396 | SULT1B1 | sulfotransferase family 1B member 1 | 2 | 2 | ||||||||
MIRT530660 | TRIM56 | tripartite motif containing 56 | 2 | 2 | ||||||||
MIRT531625 | TM4SF5 | transmembrane 4 L six family member 5 | 2 | 4 | ||||||||
MIRT532703 | TCN2 | transcobalamin 2 | 2 | 4 | ||||||||
MIRT540173 | MB21D1 | Mab-21 domain containing 1 | 2 | 2 | ||||||||
MIRT540756 | UTP6 | UTP6, small subunit processome component | 2 | 2 | ||||||||
MIRT541966 | ZNF485 | zinc finger protein 485 | 2 | 2 | ||||||||
MIRT542738 | RAF1 | Raf-1 proto-oncogene, serine/threonine kinase | 2 | 2 | ||||||||
MIRT543090 | KNSTRN | kinetochore localized astrin/SPAG5 binding protein | 2 | 2 | ||||||||
MIRT550687 | YARS | tyrosyl-tRNA synthetase | 2 | 2 | ||||||||
MIRT553466 | TNRC6A | trinucleotide repeat containing 6A | 2 | 2 | ||||||||
MIRT559980 | RELA | RELA proto-oncogene, NF-kB subunit | 2 | 2 | ||||||||
MIRT561084 | LLPH | LLP homolog, long-term synaptic facilitation | 2 | 2 | ||||||||
MIRT561738 | PLAGL2 | PLAG1 like zinc finger 2 | 2 | 2 | ||||||||
MIRT569872 | KLK10 | kallikrein related peptidase 10 | 2 | 2 | ||||||||
MIRT570264 | ARPC3 | actin related protein 2/3 complex subunit 3 | 2 | 2 | ||||||||
MIRT573431 | ALDOA | aldolase, fructose-bisphosphate A | 2 | 2 | ||||||||
MIRT573874 | PRPS1L1 | phosphoribosyl pyrophosphate synthetase 1-like 1 | 2 | 2 | ||||||||
MIRT576905 | Poteg | POTE ankyrin domain family, member G | 2 | 2 | ||||||||
MIRT607934 | ANG | angiogenin | 2 | 2 | ||||||||
MIRT609472 | RPL7L1 | ribosomal protein L7 like 1 | 2 | 4 | ||||||||
MIRT612179 | EMC3 | ER membrane protein complex subunit 3 | 2 | 2 | ||||||||
MIRT613428 | GALNT6 | polypeptide N-acetylgalactosaminyltransferase 6 | 2 | 2 | ||||||||
MIRT613746 | GPR155 | G protein-coupled receptor 155 | 2 | 2 | ||||||||
MIRT615034 | DIS3 | DIS3 homolog, exosome endoribonuclease and 3'-5' exoribonuclease | 2 | 2 | ||||||||
MIRT615565 | JPH2 | junctophilin 2 | 2 | 2 | ||||||||
MIRT615937 | MAP1LC3B | microtubule associated protein 1 light chain 3 beta | 2 | 2 | ||||||||
MIRT616643 | LRAT | lecithin retinol acyltransferase | 2 | 4 | ||||||||
MIRT630890 | SLC25A33 | solute carrier family 25 member 33 | 2 | 2 | ||||||||
MIRT636542 | FAM126B | family with sequence similarity 126 member B | 2 | 2 | ||||||||
MIRT641392 | NUBPL | nucleotide binding protein like | 2 | 2 | ||||||||
MIRT641410 | SCN2B | sodium voltage-gated channel beta subunit 2 | 2 | 2 | ||||||||
MIRT643184 | HYPK | huntingtin interacting protein K | 2 | 2 | ||||||||
MIRT652600 | TIMM8A | translocase of inner mitochondrial membrane 8A | 2 | 2 | ||||||||
MIRT653974 | SEMA7A | semaphorin 7A (John Milton Hagen blood group) | 2 | 2 | ||||||||
MIRT655692 | NUDT3 | nudix hydrolase 3 | 2 | 2 | ||||||||
MIRT660734 | ALG14 | ALG14, UDP-N-acetylglucosaminyltransferase subunit | 2 | 4 | ||||||||
MIRT661604 | C2orf15 | chromosome 2 open reading frame 15 | 2 | 2 | ||||||||
MIRT663284 | ZNF675 | zinc finger protein 675 | 2 | 2 | ||||||||
MIRT666337 | SKAP2 | src kinase associated phosphoprotein 2 | 2 | 2 | ||||||||
MIRT666636 | RBMS2 | RNA binding motif single stranded interacting protein 2 | 2 | 2 | ||||||||
MIRT667125 | OCIAD2 | OCIA domain containing 2 | 2 | 2 | ||||||||
MIRT670412 | ELP2 | elongator acetyltransferase complex subunit 2 | 2 | 2 | ||||||||
MIRT671119 | ZNF573 | zinc finger protein 573 | 2 | 2 | ||||||||
MIRT671152 | ANKRD9 | ankyrin repeat domain 9 | 2 | 2 | ||||||||
MIRT671336 | FAM71F2 | family with sequence similarity 71 member F2 | 2 | 2 | ||||||||
MIRT671867 | ZNF429 | zinc finger protein 429 | 2 | 2 | ||||||||
MIRT671972 | IKZF3 | IKAROS family zinc finger 3 | 2 | 2 | ||||||||
MIRT672062 | KIAA0930 | KIAA0930 | 2 | 2 | ||||||||
MIRT672652 | SLC25A16 | solute carrier family 25 member 16 | 2 | 4 | ||||||||
MIRT672671 | GTF2H5 | general transcription factor IIH subunit 5 | 2 | 2 | ||||||||
MIRT672768 | UBE2V2 | ubiquitin conjugating enzyme E2 V2 | 2 | 2 | ||||||||
MIRT672927 | LRRC2 | leucine rich repeat containing 2 | 2 | 2 | ||||||||
MIRT673156 | C1orf50 | chromosome 1 open reading frame 50 | 2 | 2 | ||||||||
MIRT673270 | RUNDC1 | RUN domain containing 1 | 2 | 2 | ||||||||
MIRT673329 | THAP1 | THAP domain containing 1 | 2 | 2 | ||||||||
MIRT673348 | SLC35F6 | solute carrier family 35 member F6 | 2 | 2 | ||||||||
MIRT673664 | ZNF440 | zinc finger protein 440 | 2 | 2 | ||||||||
MIRT673901 | DCTN6 | dynactin subunit 6 | 2 | 2 | ||||||||
MIRT674399 | MYCBP | MYC binding protein | 2 | 2 | ||||||||
MIRT674523 | PRR23A | proline rich 23A | 2 | 2 | ||||||||
MIRT674831 | ADAMTS4 | ADAM metallopeptidase with thrombospondin type 1 motif 4 | 2 | 2 | ||||||||
MIRT675064 | FGD6 | FYVE, RhoGEF and PH domain containing 6 | 2 | 2 | ||||||||
MIRT675078 | CCR6 | C-C motif chemokine receptor 6 | 2 | 2 | ||||||||
MIRT675123 | FSD2 | fibronectin type III and SPRY domain containing 2 | 2 | 2 | ||||||||
MIRT679399 | IL10RB | interleukin 10 receptor subunit beta | 2 | 2 | ||||||||
MIRT686608 | TMEM70 | transmembrane protein 70 | 2 | 2 | ||||||||
MIRT690371 | ZSWIM7 | zinc finger SWIM-type containing 7 | 2 | 2 | ||||||||
MIRT694464 | LRTOMT | leucine rich transmembrane and O-methyltransferase domain containing | 2 | 2 | ||||||||
MIRT695706 | OLA1 | Obg like ATPase 1 | 2 | 2 | ||||||||
MIRT696846 | WDR13 | WD repeat domain 13 | 2 | 2 | ||||||||
MIRT700894 | PER2 | period circadian clock 2 | 2 | 2 | ||||||||
MIRT701924 | MLLT1 | MLLT1, super elongation complex subunit | 2 | 2 | ||||||||
MIRT704918 | CCDC36 | coiled-coil domain containing 36 | 2 | 2 | ||||||||
MIRT706211 | ACOT9 | acyl-CoA thioesterase 9 | 2 | 2 | ||||||||
MIRT706546 | GJD2 | gap junction protein delta 2 | 2 | 2 | ||||||||
MIRT706727 | RFK | riboflavin kinase | 2 | 2 | ||||||||
MIRT707366 | ORAI2 | ORAI calcium release-activated calcium modulator 2 | 2 | 2 | ||||||||
MIRT707416 | RRP7A | ribosomal RNA processing 7 homolog A | 2 | 2 | ||||||||
MIRT710646 | GLUL | glutamate-ammonia ligase | 2 | 2 | ||||||||
MIRT712298 | PGM2L1 | phosphoglucomutase 2 like 1 | 2 | 2 | ||||||||
MIRT713709 | HIST3H2BB | histone cluster 3 H2B family member b | 2 | 2 | ||||||||
MIRT713751 | SLC9A8 | solute carrier family 9 member A8 | 2 | 2 | ||||||||
MIRT716423 | VPS53 | VPS53, GARP complex subunit | 2 | 2 | ||||||||
MIRT717169 | UCHL3 | ubiquitin C-terminal hydrolase L3 | 2 | 2 | ||||||||
MIRT718877 | PDIA3 | protein disulfide isomerase family A member 3 | 2 | 2 | ||||||||
MIRT720096 | SPTLC3 | serine palmitoyltransferase long chain base subunit 3 | 2 | 2 |
miRNA-Drug Associations | ||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
miRNA-Drug Resistance Associations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|